COVID-19 Response

Our Covid-19 Response Overview

In response to the current pandemic, the African Pharma Conference, a collaboration between AUDA-NEPAD and DFS Africa, has launched the Connecting the Dot Initiative (CDI).

Through the series of webinars organised during the COVID-19 pandemic and initiatives developed in the implementation of the Pharmaceutical Manufacturing Plan for Africa (PMPA), we have built strong relationships with principal actors in the pharmaceutical and manufacturing ecosystem. The PMPA implementation initiatives have received the support of the African Union Commission (AUC), African Governments, UN Agencies, Development Finance Institutions, Private sector investors and local pharmaceutical companies.

In the spirit of the PMPA, we have engaged both public sector and private sector off-takers including WHO, Africa CDC and national bodies like CACOVID In Nigeria who have detailed their approach to procurement and standards required for COVID-19 priority products. In the coming days and weeks, we will expand the list of off-takers to cover all national bodies across Africa.

The CDI seeks to connect local manufacturers to off-takers and we are now reaching to local manufacturers to submit their interest through this website.

As part of this initiative, we have reached out to Development Finance Institutions (DFIs) and development agencies who have re-iterated the different assistance measures for African countries which currently totals over $87 billion as can be seen below:


African Development Bank Group unveils $10 billion Response Facility to curb COVID-19.
Read More

Afreximbank Unveils $3m COVID-19 Grant for African Countries.
Read More

World Bank Group unveils $55 billion fund for Africa, over the next 15 months to help countries protect the poor and vulnerable, support businesses, and bolster economic recovery.
Read More

IMF to provide financial assistance upwards of US$18 billion to 44 African countries through the Rapid Credit Facility (RCF), an interest-free lending instrument available to low-income members.
Read More


CACOVID has raised 26 billion naira in private sector contribution in combating COVID.
Read More


The priority products and services needed across African countries includes:

·       Medical testing equipment

·       Medical equipment design

·       Protective equipment for healthcare workers, such as masks, gowns and sanitiser

·       Hotel rooms

·       Transport and logistics, for moving goods or people

·       Manufacturing equipment

·       Warehouse or office space, for medical use or storage

·       Expertise or support on IT, manufacturing, construction, project management, procurement or engineering

·       Social care or childcare

If you are interested in providing any of the above, please fill the form here. You’ll be asked some questions about the type of support you can give. You’ll then be contacted as soon as possible if your support is needed.

You’ll need your company number and contact details in addition to the products or services you can provide.


Our approach is to connect manufacturers or suppliers of all the essential products needs on the continent to institutions and organisations that would serve as Off Takers.

What We Offer

We simply connect the dots. We recommend standards to off takers, finalize sales, finance and advise local manufacturers and smoothen the logistic process.

The implementation approach will rely on connecting the dots of the existing partnerships we have developed within the pharmaceutical and manufacturing ecosystem since the inception of our partnership with AUDA-NEPAD.

Our Approach is divided into 2: Sourcing and Repurposing


Submit your interest

This approach hinges on production capabilities of existing facilities or arrangements with foreign suppliers. This would be a simple ordering and supply transaction.

The following palliative medical products has been highlighted as critical to the fight against COVID-19 and is split into two: Covid19 Priority products and Other Essential Medicines produced

           I.     COVID-19 Priority Medicines for Manufacture

·       Paracetamol

·       Chloroquine

·       Hydroxychloroquine

·       Azithromycin

·       Oseltamivir

·       Lopinavir / ritonavir

·       Valacyclovir

          II.     Other Priority Essential Medicines Produced

·       ARVs

·       Anti-malarials

·       Anti-HPT,  anti-diabetics

·       Antibiotics

·       Etc

        III.     Personal Protective Equipment (PPE)

·       Gloves

·       Face Masks

·       Visors

·       Footwear

·       Aprons

·       Body Bags

·       Clinical Waste Bags

·       Eye Protection (glasses and face shields)

·       Face Mask II

·       Face Masks IIR

·       Respirators FFP2

·       Respirators FFP3

·       Fit Test (Solutions) for masks

·       Fit Test (Full Kits) for masks

·       General Purpose Detergent

·       Gloves (Exam only NOT surgeons)

·       Gowns

·       Hand Hygiene

·       Swabs

·       Covid19 Testing Kits

·       Or extraordinary items or services specific to Covid-19 response; e.g. temporary buildings, staff, etc.


        IV.         Testing Kits (Antigen and Antibody)


Technical Standards Expected



We adhere to these standards:

·       If intended to protect the wearer: EU regulation 2016/425 on Personal Protective Equipment (PPE)

·       If intended to protect the patient: Medical Devices Regulations (MDR 2002) which implements Directive 93/42/EEC on medical devices

·       If you claim it is dual purpose (MD and PPE), the product must comply with MDR. In addition, they must meet the relevant essential health and safety requirements (EHSR) of the PPE Directive


Submit your interest

This approach hinges on repurposing existing manufacturing practices or facilities to meet the specific COVID 19 products like:

·       PPE’s

·       Testing Kits, and

·       Isolation Centre’s support Kits

Submit your interest

Use this service to tell us how your business might be able to help with the response to the coronavirus (COVID-19) pandemic.